Novo Holdings, the holding and investment company of the Novo Nordisk Foundation, has completed its acquisition of the Genetics division of UK listed aquaculture specialist Benchmark Holdings. Benchmark Holdings agreed to divest...
Benchmark Genetics under new ownership
read more
